Precision Value & Health team PRECISIONxtract has announced the addition of two senior executives as it launches its digital data tool OncoGenius. Bruce Edelen will step into the role of SVP, OncoGenius franchise lead and Ron Schleif will serve as SVP, oncology provider group management and survey operations.
Edelen and Schleif co-founded Oncology Reimbursement Management (ORM), which PRECISIONxtract acquired earlier this year.
“[W]e are very excited by the addition of Bruce and Ron to our group,” Bruce Leavitt, president of PRECISIONxtract, said in a statement. “They bring a unique value to life science companies with their rare combination of oncology commercialization savvy and very strong relationships with oncology providers.”
Edelen brings 40 years of experience to the company, including 30 years at Eli Lilly, where he led the oncology reimbursement team for eight years. Schleif also worked at Eli Lilly for 35 years, during which he led global launch strategies in oncology.
